Esophagogastric junction polyp
ICD-10 K22.82 is a billable code used to indicate a diagnosis of esophagogastric junction polyp.
Esophagogastric junction polyp (EGJ polyp) is a benign growth located at the junction of the esophagus and stomach. Clinically, patients may present with symptoms such as dysphagia (difficulty swallowing), gastroesophageal reflux disease (GERD), or epigastric pain. Anatomically, the esophagogastric junction is a critical area where the esophagus connects to the stomach, and polyps in this region can disrupt normal function. Disease progression can vary; while many EGJ polyps remain asymptomatic, some may lead to complications such as obstruction or bleeding. Diagnostic considerations include endoscopy, where the polyp can be visualized and potentially biopsied to rule out malignancy. Histological examination is crucial for confirming the diagnosis and determining the appropriate management plan. Regular monitoring may be necessary, especially in patients with a history of GERD or other risk factors for esophageal pathology.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K22.82 specifically covers esophagogastric junction polyps, which are benign lesions found at the junction of the esophagus and stomach. It does not cover malignant lesions or other types of esophageal polyps.
K22.82 should be used when a patient has a confirmed diagnosis of an esophagogastric junction polyp, particularly when symptoms or findings are directly related to this specific condition, differentiating it from other esophageal disorders.
Documentation should include endoscopic findings, biopsy results confirming the presence of a polyp, and any relevant patient history such as symptoms or previous gastrointestinal conditions.
